Nanotechnology : Woburn

Angstrom Medica, Inc.

Benj — Wed, 23 Aug 2006 17:31:15 +0000

Ticker Id

Web url

http://www.angstrommedica.com/

Contact Email

info@angstrommedica.com

Short description

Street address

150-A New Boston Street

Zip or postal code

01801

Telephone

781.933.6121

Fax

Foundation date

Ceo, president

Number of employees

Long description

Angstrom Medica is a development-stage company founded in June 2001 by Edward Ahn, Ph.D., Sudhir Borgonha M.D. and Darren Obrigkeit Ph.D. Angstrom Medica is a spin-off from the Nanostructured Materials Research Laboratory in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT).

The company's mission is to develop and commercialize its proprietary nanotechnology to transform the standard of care in areas of medicine where biomaterial technology drives clinical outcomes. Angstrom Medica's technology platform can be applied to a wide range of medical applications, including orthopedic surgery, drug delivery, and cardiovascular medicine. Our initial products will target orthopedic implants for trauma, reconstructive and plastic surgery.

Additional Commentaries and remarks

Patents

Aphios, Corp.

Benj — Sat, 19 Aug 2006 22:39:38 +0000

Ticker Id

Web url

http://www.aphios.com/

Contact Email

mail@aphios.com

Short description

Street address

3-E Gill Street, New Boston Park

Zip or postal code

01801

Telephone

(001) (781) 932-6933

Fax

(001) (781) 932-6865

Foundation date

Ceo, president

Number of employees

Long description

Aphios R&D activities encompass four areas: infectious diseases, oncology, drug delivery nanotechnology and quality-of-life medicines, with a discovery focus on anti-infectives. Aphios is developing antiviral therapeutics against HIV, influenza, smallpox and SARS as well as oral-care and MDR antimicrobials from the Company's library of unique marine microorganisms, isolated from normal to extremeophilic environments.

Additional Commentaries and remarks

Patents

BioTrove, Inc.

Benj — Tue, 22 Aug 2006 19:08:06 +0000

Ticker Id

Web url

http://www.biotrove.com/

Contact Email

info@biotrove.com

Short description

Street address

12 Gill Street, Suite 4000

Zip or postal code

01801-1728

Telephone

781-721-3600

Fax

781-721-3601

Foundation date

Ceo, president

Number of employees

Long description

BioTrove, Inc. is a privately held biotechnology company focused on leveraging revolutionary micro- and nano-scale engineering solutions that improve the efficiency and productivity of drug discovery.

BioTrove has two core nanofluidic platforms: the Living Chip and Momentum Assay Development and Screening. The Living Chip is a miniaturized platform for massively parallel liquid processing to store, handle, synthesize, and screen a high-density of nanoliter-scale samples in a microplate footprint. BioTrove's second technology, the Lab-on-a-Tape, is a nanofluidic platform that enables rapid assay development and high-throughput screening of targets with label-free assays. The company's first commercial agreement is a research collaboration with Pfizer, Inc. for the Lab-on-a-Tape platform.

BioTrove provides pharmaceutical and biotechnology partners with nanovolume sample handling, storage, and assay capabilities using its Living Chip and Lab-on-a-Tape technologies. In addition, the company plans to purchase, in-license, or form partnerships and joint ventures to obtain the additional inputs necessary in the discovery process, including targets, compound libraries, assay technologies, genetic libraries, and informatics.

Additional Commentaries and remarks

Patents

Energetiq Technology

Benj — Mon, 28 Aug 2006 14:14:57 +0000

Ticker Id

Web url

http://www.energetiq.com/

Contact Email

info@energetiq.com

Short description

Street address

7 Constitution Way

Zip or postal code

01801

Telephone

+1 (781) 939-0763

Fax

+1 (781) 939-0769

Foundation date

Ceo, president

Number of employees

Long description

Energetiq is a developer and manufacturer of short wavelength light sources for use in advanced scientific and engineering applications.

Energetiq's light sources are based on new technology that generates high brightness light in the 1nm to 250nm range with high reliability in a compact package.

Energetiq's light sources can be used for; EUV Lithography, Metrology and Resist development, Soft X-Ray Microscopy and a variety of applications where synchrotron radiation has traditionally been used.

Additional Commentaries and remarks

Patents

Inanovate

Benj — Sat, 02 Sep 2006 15:43:31 +0000

Ticker Id

Web url

http://www.inanovate.com/

Contact Email

Short description

Street address

10 Tower Office Park, Suite 500

Zip or postal code

01801

Telephone

617-610-1712

Fax

Foundation date

Ceo, president

David Ure

Number of employees

Long description

Inanovate is based on ten years of research at the University of Birmingham's world-leading Nano Physics Research Lab (UK). Inanovate uses a proprietary platform to create nano-scale surface structures through a unique process capable of nano-meter precision in a time and cost effective way.

Inanovate's surface structures are created from novel nano-scale building blocks which exhibit unique physical properties that differ significantly from those of their bulk counterpart.

Leveraging this unique platform and expertise, Inanovate is developing nano-structured biochip substrates to facilitate the next generation in biochip technology.

Inanovate's substrates will transition biochips from micro-array technology, to nano-arrays an order of magnitude more sensitive and consistent. Such performance improvements will both improve existing drug development procedures, and enable biochip technology to access broader reaching diagnostic markets.

Additional Commentaries and remarks

Patents

IntelliSense Software Corporation

Benj — Thu, 24 Aug 2006 12:58:11 +0000

Ticker Id

Web url

http://www.intellisensesoftware.com/

Contact Email

Short description

Street address

600 West Cummings Park, Suite 2000

Zip or postal code

01801

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

With customers in 17 countries on three continents, and partnerships with dozens of leading MEMS research institutes worldwide, IntelliSense Software is the leading innovator in MEMS design and development.

Additional Commentaries and remarks

Patents

Nantero, Inc.

Benj — Thu, 24 Aug 2006 12:56:24 +0000

Ticker Id

Web url

http://www.nantero.com/

Contact Email

info@nantero.com

Short description

Street address

25-D Olympia Avenue

Zip or postal code

01801

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

Nantero, Inc. is building a high density nonvolatile random access memory chip, which can replace DRAM (dynamic RAM), SRAM (static RAM), flash memory, and ultimately hard disk storage--in other words a universal memory chip suitable for countless existing and new applications in the field of electronics. The target markets in aggregate exceed $100B in revenue per year. Nantero's product is called NRAM (Nanotube-based/ Nonvolatile RAM), developed using proprietary concepts and methods derived from leading-edge research in nanotechnology.

Nantero has created multiple prototype devices, including an array of ten billion suspended nanotube junctions on a single silicon wafer. Nantero's design for NRAM involves the use of suspended nanotube junctions as memory bits, with the "up" position representing bit zero and the "down" position representing bit one. Bits are switched between states through the application of electrical fields. The wafer was produced using only standard semiconductor processes, maximizing compatibility with existing semiconductor factories.

Additional Commentaries and remarks

Patents

SRU Biosystems

Benj — Wed, 23 Aug 2006 16:40:49 +0000

Ticker Id

Web url

http://www.srubiosystems.com/

Contact Email

info@srubiosystems.com

Short description

Street address

14-A Gill Street

Zip or postal code

01801

Telephone

781-933-7255

Fax

781-933-5960

Foundation date

Ceo, president

Number of employees

Long description

The SRU BIND Biosensor technology represents a fundamental advance in the ability to monitor label-free biochemical interactions with high sensitivity and high throughput. SRU is incorporating its technology into microtiter plates, microarray slides, and microfluid formats to create tools that can be used to answer important biological questions for genomics, proteomics, clinical diagnostic tests, and pharmaceutical target screening.

Additional Commentaries and remarks

Patents

U.S. Genomics, Inc.

Benj — Wed, 23 Aug 2006 16:43:19 +0000

Ticker Id

Web url

http://www.usgenomics.com/

Contact Email

info@usgenomics.com

Short description

Street address

12 Gill Street, Suite 4700

Zip or postal code

01801

Telephone

(781) 937-5550

Fax

(781) 938-0060

Foundation date

Ceo, president

Number of employees

Long description

U.S. Genomics (USG) is developing technologies for the direct analysis of single, unamplified molecules of biological significance for the global life sciences industry. The mission of U.S. Genomics is to be the worlds pre-eminent provider of novel platform technology that allows genetic, functional genomics and protein analyses; this includes the associated instrumentation, software, methods, reagents, kits and consulting services, for the direct analysis of DNA, RNA and proteins. USG, along with its strategic partners, will design, develop, manufacture, market and sell its proprietary portfolio of products and specialized applications to life science researchers in the pharmaceutical and biotech industries and academia, as well as healthcare providers and contract service organizations within the healthcare industry. It is USG's ultimate vision to be the premiere provider of enabling technology for the realization of personalized medicine.

U.S. Genomics was founded in 1997 by Eugene Chan, who invented and patented key aspects of the GeneEngine technology and its associated direct, linear analysis method for the analysis of DNA. The company has raised a total of $25 million to date from HealthCare Ventures, StillRiver Fund, CB Health Ventures, and private individuals. Following four years of intensive technology development, U.S. Genomics produced a research version of the GeneEngine platform in 2002. This first-generation technology will form the basis for the Company's first product, to be launched in 2004 as a general analytical instrument for direct quantitation of unamplified molecules in a biological sample (e.g. quantitation of RNA molecules for RNA expression analysis).

Additional Commentaries and remarks

Patents

VisEn Medical, Inc.

Benj — Wed, 13 Dec 2006 14:10:16 +0000

Ticker Id

Web url

http://www.visenmedical.com/

Contact Email

Short description

Street address

12B Cabot Road

Zip or postal code

01801

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

Founded in 2000, the Company's initial technology platforms were developed at the Massachusetts General Hospital and Harvard Medical School under the direction of Dr. Ralph Weissleder, Professor of Radiology and Director of the Center for Molecular Imaging Research at the MGHl.

The Company's FMT System and Optical Probe Portfolio harness the well-known power of fluorescent technology in vivo by providing quantifiable molecular reporting in a range of diseases from deep within the body. These powerful sets of technologies open the door to VisEn's two breakthrough market opportunities: imaging of disease progression and pharmaceutical activity in animals for general research and pharmaceutical drug development, and clinical molecular imaging of disease processes in humans. With these groundbreaking products, a deep understanding of the chemistries and biologies of agents and disease, and through applications developed with leading research and pharmaceutical partners, VisEn is giving meaning and metrics to molecular imaging today.